Sustained and "sleeper" effects of group metacognitive training for schizophrenia a randomized clinical trial

JAMA Psychiatry

Volumn 71, Issue 10, 2014, Pages 1103-1111

  Moritz, Steffen ^a   Veckenstedt, Ruth ^a   Andreou, Christina ^a   Bohn, Francesca ^a   Hottenrott, Birgit ^a   Leighton, Lucy ^a   Köther, Ulf ^a   Woodward, Todd S ^b,c   Treszl, András ^a   Menon, Mahesh ^b   Schneider, Brooke C ^a   Pfueller, Ute ^d   Roesch Ely, Daniela ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BC Mental Health and Addictions Research Institute   (Canada)

^d Center for Psychosocial Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COGNITIVE THERAPY; COGPACK; CONTROLLED STUDY; DELUSION; DSM-IV; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; METACOGNITIVE TRAINING; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOTIC SYMPTOM RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SELF ESTEEM; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; CLINICAL TRIAL; COGNITION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SELF CONCEPT;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SINGLE-BLIND METHOD;

EID: 84907718720     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.1038     Document Type: Article

References (73)

1. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: ameta-analysis. Lancet. 2009;373 (9657):31-41.
2. Lieberman JA, Stroup TS, McEvoy JP, et al; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209- 1223.
3. Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatr Clin North Am. 2007;30 (3):437-452.
4. Velligan DI, Weiden PJ, Sajatovic M, et al; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(suppl 4):1-46, quiz 47-48.
5. Lora A, Kohn R, Levav I, McBain R, Morris J, Saxena S. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bull World Health Organ. 2012;90(1):47-54, 54A-54B.
6. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review ofmeta-analyses. Cognit Ther Res. 2012;36(5):427-440.
7. Lincoln TM, Suttner C, Nestoriuc Y. Wirksamkeit kognitiver Interventionen in der Reduktion schizophrener Symptomatik: eineMeta-Analyse. Psychol Rundsch. 2008;59(4):217-232. doi:10.1026/0033-3042.59.4.217.
8. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34(3):523-537.
9. Zimmermann G, Favrod J, Trieu VH, Pomini V. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: ameta-analysis. Schizophr Res. 2005;77 (1):1-9.
10. Waller H, Freeman D, Jolley S, Dunn G, Garety P. Targeting reasoning biases in delusions: a pilot study of the Maudsley Review Training Programme for individuals with persistent, high conviction delusions. J Behav Ther Exp Psychiatry. 2011;42(3): 414-421.
11. Moritz S, Vitzthum F, Randjbar S, Veckenstedt R, Woodward TS. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatry. 2010;23(6):561-569.
12. Moritz S, Andreou C, Schneider BC, et al. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia. Clin Psychol Rev. 2014;34(4):358-366.
13. Freeman D. Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev. 2007;27 (4):425-457.
14. van der GaagM, Hoffman T, Remijsen M, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res. 2006;85(1-3):280-287.
15. Bentall RP, Rowse G, Shryane N, et al. The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch Gen Psychiatry. 2009;66(3):236- 247.
16. Fine C, Gardner M, Craigie J, Gold I. Hopping, skipping or jumping to conclusions? clarifying the role of the JTC bias in delusions. Cogn Neuropsychiatry. 2007;12(1):46-77.
17. Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P. Persecutory delusions: a review and theoretical integration. Clin Psychol Rev. 2001; 21(8):1143-1192.
18. Kinderman P, Bentall RP. Causal attributions in paranoia and depression: internal, personal, and situational attributions for negative events. J Abnorm Psychol. 1997;106(2):341-345.
19. Garety PA, Hemsley DR, Wessely S. Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. J Nerv Ment Dis. 1991;179(4):194-201.
20. Lincoln TM, Ziegler M, Mehl S, Rief W. The jumping to conclusions bias in delusions: specificity and changeability. J Abnorm Psychol. 2010;119(1): 40-49.
21. Moritz S, Woodward TS. Metacognitive control over false memories: a key determinant of delusional thinking. Curr Psychiatry Rep. 2006;8 (3):184-190.
22. Woodward TS, Buchy L, Moritz S, Liotti M. A bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample. Schizophr Bull. 2007;33(4):1023-1028.
23. Woodward TS, Moritz S, Menon M, Klinge R. Belief inflexibility in schizophrenia. Cogn Neuropsychiatry. 2008;13(3):267-277.
24. Veckenstedt R, Randjbar S, Vitzthum F, Hottenrott B, Woodward TS, Moritz S. Incorrigibility, jumping to conclusions, and decision threshold in schizophrenia. Cogn Neuropsychiatry. 2011;16(2):174-192.
25. Freeman D, Garety P, Fowler D, et al. The London-East Anglia randomized controlled trial of cognitive-behaviour therapy for psychosis, IV: self-esteem and persecutory delusions. Br J Clin Psychol. 1998;37(pt 4):415-430.
26. Moritz S, Werner R, von Collani G. The inferiority complex in paranoia readdressed: a study with the Implicit Association Test. Cogn Neuropsychiatry. 2006;11(4):402-415.
27. Brune M. "Theory ofmind" in schizophrenia: a review of the literature. Schizophr Bull. 2005;31 (1):21-42.
28. Aghotor J, Pfueller U, Moritz S, Weisbrod M, Roesch-Ely D. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry. 2010;41(3):207-211.
29. Moritz S, Woodward TS. Metacognitive training for schizophrenia patients (MCT): a pilot study on feasibility, treatment adherence, and subjective efficacy. Ger J Psychiatry. 2007;10(3):69-78. http://www.gjpsy.uni-goettingen.de/index-Dateien/Page1421.htm. Accessed June 27, 2014.
30. Moritz S, Kerstan A, Veckenstedt R, et al. Further evidence for the efficacy of ametacognitive group training in schizophrenia. Behav Res Ther. 2011;49(3):151-157.
31. Ross K, Freeman D, Dunn G, Garety P. A randomized experimental investigation of reasoning training for people with delusions. Schizophr Bull. 2011;37(2):324-333.
32. Moritz S, Veckenstedt R, Bohn F, et al. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr Res. 2013;151(1-3):61-69.
33. Moritz S, Veckenstedt R, Randjbar S, Vitzthum F, Woodward TS. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med. 2011;41(9):1823-1832.
34. Kumar D, Zia Ul Haq M, Dubey I, et al. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur J Psychother Counselling. 2010;12(2):149-158. doi:10.1080/13642537.2010.488875.
35. Balzan RP, Delfabbro PH, Galletly CA, Woodward TS. Metacognitive training for patients with schizophrenia: Preliminary evidence for a targeted, single-module programme [published online October 24, 2013].Aust N Z J Psychiatry. doi: 10.1177/0004867413508451.
36. Favrod J, Rexhaj S, Bardy S, et al. Sustained antipsychotic effect of meta cognitive training in psychosis: a randomized-controlled study. Eur Psychiatry. 2014;29(5):275-281.
37. Favrod J, Maire A, Bardy S, Pernier S, Bonsack C. Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J Adv Nurs. 2011;67(2):401-407.
38. Rocha NB, Queiros C.Metacognitive and social cognition training (MSCT) in schizophrenia: a preliminary efficacy study. Schizophr Res. 2013; 150(1):64-68.
39. FioravantiM, Bianchi V, Cinti ME. Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. BMC Psychiatry. 2012;12:64.
40. Lincoln TM, Lullmann E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia: a systematic review. Schizophr Bull. 2007;33(6):1324-1342.
41. Marker KR. COGPACK Manual, Version 5.9. Ladenburg, Germany: Marker Software; 2003.
42. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
43. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994;53 (1):31-40.
44. Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89(1-3):119- 122.
45. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879-889.
46. Speechley WJ, Whitman JC, Woodward TS. The contribution of hypersalience to the "jumping to conclusions" bias associated with delusions in schizophrenia. J Psychiatry Neurosci. 2010;35(1):7- 17.
47. Moritz S, Veckenstedt R, Hottenrott B, Woodward TS, Randjbar S, Lincoln TM. Different sides of the same coin? intercorrelations of cognitive biases in schizophrenia. Cogn Neuropsychiatry. 2010;15(4):406-421.
48. Menon M, Pomarol-Clotet E, McKenna PJ, McCarthy RA. Probabilistic reasoning in schizophrenia: a comparison of the performance of deluded and non deluded schizophrenic patients and exploration of possible cognitive underpinnings. Cogn Neuropsychiatry. 2006;11(6): 521-536.
49. Moritz S, Woodward TS. Jumping to conclusions in delusional and non-delusional schizophrenic patients. Br J Clin Psychol. 2005;44 (pt 2):193-207.
50. RothM, Decker O, Herzberg PY, Brahler E. Dimensionality and norms of the Rosenberg Self-Esteem Scale in a German general population sample. Eur J Psychol Assess. 2008;24(3):190-197. doi:10.1027/1015-5759.24.3.190.
51. World Health Organization. TheWorld Health Organization Quality of Life (WHOQOL)-BREF. Geneva, Switzerland: World Health Organization; 2004.
52. Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol. 2002;37(11):510-518.
53. Chino B, Nemoto T, Fujii C, Mizuno M. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci. 2009;63 (4):521-528.
54. Wilson BA, Cockburn J, Baddeley AD. The Rivermead Behavioural Memory Test. Bury St Edmunds, England: Thames Valley Test Co; 1985.
55. Reitan RM. Trail Making Test: Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory; 1992.
56. von Brickenkamp R. Test d2-Aufmerksamkeits- Belastungs-Test. 6th ed. Gottingen, Germany: Hogrefe; 1978.
57. Borm GF, Fransen J, Lemmens WA. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60 (12):1234-1238.
58. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123-1124.
59. Liang KY, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Indian J Statistics, Ser B. 2000;62(pt 1): 134-148. http://sankhya.isical.ac.in/search/62b1/fpaper7.pdf. Accessed June 27, 2014.
60. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med. 2009;28(20):2509-2530.
61. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53(3):983-997.
62. Carpenter JR, Kenward MG. Missing Data in Randomised Controlled Trials-A Practical Guide. Birmingham, England: National Institute for Health Research; 2008.
63. Erdfelder E, Faul F, Buchner A. GPOWER: a general power analysis program. Behav Res Methods. 1996;28(1):1-11. doi:10.3758/BF03203630.
64. Novick D, Haro JM, Suarez D, Vieta E, Naber D. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophr Res. 2009;108 (1-3):223-230.
65. Jaaskelainen E, Juola P, Hirvonen N, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296-1306.
66. Balzan RP, Delfabbro PH, Galletly CA, Woodward TS. Over-adjustment or miscomprehension? a re-examination of the jumping to conclusions bias. Aust N Z J Psychiatry. 2012;46(6):532-540.
67. Garety PA, Freeman D. The past and future of delusions research: from the inexplicable to the treatable. Br J Psychiatry. 2013;203(5):327-333.
68. Moritz S, Veckenstedt R, Randjbar S, Vitzthum-Bohn F. Individualized Meta cognitive Therapy (MCT+) for people with psychosis. Universitatsklinikum Hamburg-Eppendorf website. www.uke.de/mct-plus. Accessed June 27, 2014.
69. Staring AB, Ter Huurne MA, van der Gaag M. Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. J Behav Ther Exp Psychiatry. 2013;44(3): 300-306.
70. Klingberg S, WolwerW, Engel C, et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull. 2011;37(suppl 2):S98-S110.
71. Perivoliotis D, Cather C. Cognitive behavioral therapy of negative symptoms. J Clin Psychol. 2009;65(8):815-830.
72. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. Ameta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168(5):472-485.
73. Wiesjahn M, Brabban A, Jung E, et al. Are continuum beliefs about psychotic symptoms associated with stereotypes about schizophrenia? Psychosis. In press.